<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00620360</url>
  </required_header>
  <id_info>
    <org_study_id>279/07/CE/FBM</org_study_id>
    <nct_id>NCT00620360</nct_id>
  </id_info>
  <brief_title>Acute Effect of Fructose on Lipid Metabolism and Gender Differences</brief_title>
  <official_title>Acute Effect of Fructose on Lipid Metabolism and Gender Differences</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Lausanne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Lausanne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      It has been widely documented that fructose overfeeding increases plasma triglycerides and
      hepatic de novo lipogenesis, and impairs insulin sensitivity in healthy male volunteers. The
      effect of gender on the metabolic responses to fructose remains an important open question,
      however.

      The objective of this study is to compare the effect of an acute oral fructose load on
      carbohydrate and lipid metabolism in healthy young males and females.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study is aimed at comparing the effects of oral fructose on several specific metabolic
      pathways in males and females.Participants will receive an isoenergetic diet containing 55%
      carbohydrate, 15% protein and 35% lipids for three days prior to testing. After this period
      of controlled diet, they will be studied for 2 hours in the post-absorptive state (Time 0-120
      min) and over a 6 hours period (Time 120-480 min) during which they will receive 4 loads of
      0,30 g/kg fat free mass U-13C labelled fructose, at times 120, 180, 240, 300. Throughout the
      study, deuterated glucose and glycerol will be infused to monitor whole body glucose
      production and glycerol turnover.

      The following parameters will be monitored in basal conditions and after the ingestion of the
      load of fructose:

        -  Glycerol turnover(glycerol 2H5)

        -  de novo lipogenesis (incorporation of 13C into palmitate of VLDLs)

        -  whole body energy expenditure and net substrate oxydation (indirect calorimetry)

        -  net fructose oxidation (breath 13CO2)

        -  glucose turnover: (6,6 2H2 Glucose)

        -  plasma glucose, free fatty acids, ketone bodies, lactate, insulin, triacylglycerol,
           total cholesterol, VLDL, LDL, and HDL subfractions

      An adipose tissue (periumbilical subcutaneous) biopsy will be obtaine by needle aspiration
      under local anesthesia in fasting conditions (time 0 min) and after fructose (time 480 min)
      to assess the effects of fructose on adipose gene expression profile. Key genes involved in
      the regulation of carbohydrate (GLUT 4, hexokinase, PDH-kinase), lipid (FAT-CD36, FABP,
      acetylCoA carboxylase, malonyl-CoA decarboxylase, PPARg) and energy metabolism (PGC-1a,
      UCP2)will be monitored

      Results obtained in males and females will be compared with two-way analysis of variance
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">December 2008</completion_date>
  <primary_completion_date type="Actual">December 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hepatic de novo lipogenesis</measure>
    <time_frame>acute effect of dietary fructose (within 6 hours)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Whole body lipid oxidation, glucose turnover, glycerol turnover, plasma substrates, hormone and energy expenditure (free fatty acid, glucose, lactate, beta-hydroxybutyrate, glycerol, VLDL- Triglycerides and insulin) expression of key adipose genes</measure>
    <time_frame>acute effect of fructose (within 6 hours)</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">18</enrollment>
  <condition>Lipid Metabolism</condition>
  <arm_group>
    <arm_group_label>fructose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>acute fructose administration</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>fructose</intervention_name>
    <description>acute administration of 4 times 0.3g fructose/kg lean body mass</description>
    <arm_group_label>fructose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Fructose</intervention_name>
    <description>acute administration of 4 times 0.3 g/kg fat-free mass oral fructose</description>
    <arm_group_label>fructose</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males and females

          -  Age 18-35

          -  Healthy

          -  Body mass indexes (BMI) between 19 and 25 kg/m2

          -  Informed consent obtained

        Exclusion Criteria:

          -  Smokers

          -  Alcohol intake &gt; 30g/day

          -  Drug abuse

          -  Diabetes mellitus
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luc Tappy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Lausanne</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Vaudois</name>
      <address>
        <city>Lausanne</city>
        <state>Vaud</state>
        <zip>1005</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>February 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 8, 2008</study_first_submitted>
  <study_first_submitted_qc>February 8, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 21, 2008</study_first_posted>
  <last_update_submitted>February 23, 2012</last_update_submitted>
  <last_update_submitted_qc>February 23, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 24, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Lausanne</investigator_affiliation>
    <investigator_full_name>Luc Tappy, MD</investigator_full_name>
    <investigator_title>Professor of physiology</investigator_title>
  </responsible_party>
  <keyword>dietary fructose</keyword>
  <keyword>plasma lipids</keyword>
  <keyword>healthy humans</keyword>
  <keyword>gender differences</keyword>
  <keyword>hepatic de novo lipogenesis</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

